SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Overview of attention for article published in EBioMedicine, December 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#26 of 5,097)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 63 news outlets
blogs: 2 blogs
twitter: 508 X users

patent: 1 patent
facebook: 1 Facebook page

Readers on

mendeley: 136 Mendeley

So far, Altmetric has seen 563 X posts from 508 X users, with an upper bound of 3,158,956 followers.

RT @2dedostesta5: @G_Commish @ejustin46 @Nk9992Nk “The decline in nasal IgA responses 9 months after infection and minimal impact of subseq…

RT @EricTopol: Why we desperately need nasal vaccines to block infections and reinfections https://t.co/hzYDvrq34M @eBioMedicine by @Felici…

@SGriffin_Lab @red_loeb @JPWeiland @PJeffcock Temporary immunity to infection gained by a high % of the UK population in the wave last Summer will also be waning now, increasing prevalence irrespective of viral evolution. To some extent it is a matter …

@Friesein The question is how long does such "sterilising immunity" last? Immunity to reinfection induced by SARS-CoV-2 infection in human hosts has been shown to wane over a period of months... https://t.co/rkkrb9uXwm

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 559 additional X posts.